Reuters logo
BRIEF-PAION grants licence to Remimazolam in Canada to Pendopharm
July 9, 2014 / 12:35 PM / 3 years ago

BRIEF-PAION grants licence to Remimazolam in Canada to Pendopharm

July 9 (Reuters) - Paion AG : * Grants licence to Remimazolam in Canada to Pendopharm * Under agreement with Pendopharm, Paion will be eligible to receive payments

of C$ 5.7 million and double digit royalties on net sales in Canada * Source text for Eikon * Further company coverage

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below